1. Market Research
  2. > Pathology Industry

Immunotherapy Industry, August 2015 Market Reports from Top Publishers

You might be interested in: Oncology, Pharmaceutical, Therapy, Vaccine, Antibody, Motor Vehicle.


 
1-10 of 21 reports for Immunotherapy

Purchase Reports From Reputable Market Research Publishers

Skin Cancer Treatment Drugs  Markets in China

Skin Cancer Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • July 2015
  • by Asia Market Information & Development Company

China's demand for Skin Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed ...

Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015

Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015

  • $ 1 750
  • Industry report
  • June 2015
  • by Delve Insight

Summary DelveInsight Report, “Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015” emphasizes on the currently active CAR-T cell products ...

Immunotherapy in Oncology Drug Pipeline Update 2015

Immunotherapy in Oncology Drug Pipeline Update 2015

  • $ 5 127
  • Industry report
  • June 2015
  • by Bioseeker

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update 2015

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

BioSeeker’s Targeting Immune Checkpoints in Cancer Immunotherapy: Drug Pipeline Update is the most up to date and comprehensive pipeline review and competitive assessment you can get on this hot and ...

Physician Views: Oncologist expectations for immunotherapy in first-line non-small-cell lung cancer

Physician Views: Oncologist expectations for immunotherapy in first-line non-small-cell lung cancer

  • $ 695
  • Industry report
  • June 2015
  • by Firstword Pharma

Much of the debate around cancer immunotherapy at the recent ASCO annual meeting focused on the commercial positioning of a new class of product – the PD-1/PD-L1 inhibitors – in second-line, non-small-cell ...

Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, & Others

Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, & Others

  • $ 3 400
  • Industry report
  • April 2015
  • by Kelly Scientific Publications

GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell ...

SLIT Tablets, Self-Administration, and Allergy Immunotherapy to 2022 : Products, Players, Markets, and Forecasts

SLIT Tablets, Self-Administration, and Allergy Immunotherapy to 2022 : Products, Players, Markets, and Forecasts

  • $ 2 850
  • Industry report
  • February 2015
  • by Greystone Research Associates

Immunotherapy involves the administration of gradually increasing doses of the allergen over a period of time to desensitize the patient. It is the only known treatment that modifies the immune response ...

Immunotherapy in Oncology: Drug Pathway Analyzer 2015

Immunotherapy in Oncology: Drug Pathway Analyzer 2015

  • $ 5 127
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 906 immunotherapy drugs known to affect more than 235 specific intracellular signaling pathways for the ...

Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2014

Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2014’, provides an overview of the Allergic Rhino-C ...

TVAX Biomedical, Inc. - Product Pipeline Review - 2014

TVAX Biomedical, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • October 2014
  • by Global Markets Direct

TVAX Biomedical, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘TVAX Biomedical, Inc. - Product Pipeline Review - 2014’, provides an overview of the TVAX Biomedical, Inc.’s ...

About 3 000 reports for Immunotherapy

Download Unlimited Documents from Trusted Public Sources

US - Economic Analysis

  • January 2013
    11 pages
  • Cancer  

    Immunotherapy  

    Interferon  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.